OpenBilldrug price receipt

NADAC week of 2026-10-14

CYCLOSPORINE MODIFIED 25 MG

For 30 capsules

Pharmacies pay

$9.41 filed

30 × $0.31377 per EA

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

Medicare Part B pays

$17.28 derived

30 × $0.576 per EA, Part B limit

Medicare's price is not your price.

OpenBill calculation · october-2026-medicare-part-b-payment-limit-files-final.zip + october-2026-ndc-hcpcs-crosswalk-final.zip · Part B limit 2026-10-01 to 2026-12-31 (file of 2026-09-17, retrieved 2026-10-18) · Part B crosswalk 2026-10-01 to 2026-12-31 (file of 2026-09-17, retrieved 2026-10-18)


The spread

1.8× estimated

Medicare pays 1.8× what pharmacies pay.

6 labelers share HCPCS J7515 on the CMS crosswalk, so its payment limit is an average across all their products billed under that code, not this NDC’s own price.

OpenBill calculation · october-2026-medicare-part-b-payment-limit-files-final.zip + october-2026-ndc-hcpcs-crosswalk-final.zip + nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17) · Part B limit 2026-10-01 to 2026-12-31 (file of 2026-09-17, retrieved 2026-10-18) · Part B crosswalk 2026-10-01 to 2026-12-31 (file of 2026-09-17, retrieved 2026-10-18)

Cost-plus estimate

$15.82 estimated

$9.41 + $1.41 (15%) + $5.00 fee per fill = $15.82

This is a model, not a price any pharmacy quoted. Shipping is not included. How it is worked out

OpenBill calculation · nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17)

Open the interactive card Change the quantity, type what you were charged, and see every record in full.

What it is

CYCLOSPORINE MODIFIED 25 MG is how the CMS NADAC file names this product. The FDA NDC Directory lists it as cyclosporine, under the trade names “CycloSPORINE, Modfied” and “Cyclosporine Modified”.

FDA gives its dosage form as capsule, liquid filled and its route as oral.

Its labelers, the companies named on the label, are Teva Pharmaceuticals USA, Inc., Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. and Apotex Corp.

FDA’s Established Pharmacologic Class for it is Calcineurin Inhibitor Immunosuppressant.

The NADAC file of 2026-10-14 prices it under 5 NDCs (National Drug Codes); the FDA directory lists 3 of them.

NADAC classes it as a generic drug (rate-setting class G), and does not mark it as sold over the counter.

What pharmacies pay

Pharmacies pay $9.41 for 30 capsules (30 × $0.31377 per EA, rounded to the cent), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-09-23. That is what pharmacies pay their suppliers, not what they charge you.

NADAC’s explanation code for it: 1, calculated from the most recently completed pharmacy survey.

All 5 NDCs

Other strengths, forms and brands

12 other products in the NADAC file share the FDA nonproprietary name cyclosporine with CYCLOSPORINE MODIFIED 25 MG.

ProductPharmacies pay per unitMedicare per unit
CEQUA 0.09% SOLUTION
brand · solution/ drops
$10.38279 per EA filed
eff. 2026-09-23
$9.33517 per EA filed
Part D 2024 average
CYCLOSPORINE 0.05% EYE EMULSION
generic · emulsion
$0.90945 to $1.18033 per EA filed
eff. 2026-09-23
$4.32927 per EA filed
Part D 2024 average
CYCLOSPORINE 25 MG CAPSULE
generic · capsule, gelatin coated
$2.5957 per EA filed
eff. 2026-09-23
$0.576 per EA derived
Part B limit 2026 Q4
CYCLOSPORINE 100 MG CAPSULE
generic · capsule, gelatin coated
$7.50676 per EA filed
eff. 2026-09-23
$1.455 per EA derived
Part B limit 2026 Q4
CYCLOSPORINE MODIFIED 25 MG this page
generic · capsule, liquid filled
$0.31377 per EA filed
eff. 2026-09-23
$0.576 per EA derived
Part B limit 2026 Q4
CYCLOSPORINE MODIFIED 50 MG
generic · capsule, liquid filled
$0.76459 per EA filed
eff. 2026-09-23
$0.7275 to $1.152 per EA derived
Part B limit 2026 Q4
CYCLOSPORINE MODIFIED 100 MG
generic · capsule, liquid filled
$1.23348 per EA filed
eff. 2026-09-23
$1.455 per EA derived
Part B limit 2026 Q4
CYCLOSPORINE MODIFIED 100 MG/ML
generic · solution
$2.03685 per ML filed
eff. 2026-09-23
$1.455 per ML derived
Part B limit 2026 Q4
GENGRAF 25 MG CAPSULE
brand · capsule
$1.86549 per EA filed
eff. 2026-01-02
$1.14257 per EA filed
Part D 2024 average
NEORAL 25 MG GELATIN CAPSULE
brand · capsule, liquid filled
$2.94566 per EA filed
eff. 2026-07-08
$3.90784 per EA filed
Part D 2024 average
NEORAL 100 MG GELATIN CAPSULE
brand · capsule, liquid filled
$11.7731 per EA filed
eff. 2026-07-08
$3.90784 per EA filed
Part D 2024 average
RESTASIS 0.05% EYE EMULSION
brand · emulsion
$10.31247 to $10.31333 per EA filed
eff. 2026-09-23
$10.19841 per EA filed
Part D 2024 average
RESTASIS MULTIDOSE 0.05% EYE
brand · emulsion
$112.32159 per ML filed
eff. 2026-09-23
$111.93625 per ML filed
Part D 2024 average

Part D is one average per brand and generic name, over every strength and form.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-01-02, 2026-07-08, 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18

OpenBill calculation · october-2026-medicare-part-b-payment-limit-files-final.zip + october-2026-ndc-hcpcs-crosswalk-final.zip · Part B limit 2026-10-01 to 2026-12-31 (file of 2026-09-17, retrieved 2026-10-18) · Part B crosswalk 2026-10-01 to 2026-12-31 (file of 2026-09-17, retrieved 2026-10-18)

Compared with its class

The middle of its 5 NDCs’ NADAC prices is $0.31377 per EA filed.

Of the 19 other products in FDA’s Calcineurin Inhibitor Immunosuppressant class priced per EA, 17 have a higher middle NADAC price and 2 a lower one. The one in the middle is NEORAL 25 MG GELATIN CAPSULE, at $2.94566 per EA filed (eff. 2026-07-08).

Prices are compared per unit, whatever the strength or dose, and a class is not a list of substitutes.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-07-08, 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

What Medicare paid

Medicare Part B’s payment limit for HCPCS J7515, for 2026-10-01 to 2026-12-31, comes to $17.28 for 30 capsules, or $0.576 per EA once converted to NADAC’s unit for this product.

Medicare Part B pays for this oral drug at a pharmacy only in specific circumstances CMS sets for this code; most prescriptions are paid by Part D.

The patient’s share under Part B (coinsurance, 20% of the limit, before deductibles and other coverage) is $0.1152 per 25 MG.

1 of the product’s 5 NDCs have this Medicare figure; the other 4 do not, and the interactive card says why for each.

Medicare's price is not your price.

What to ask at the counter

None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.